Protein ubiquitination is a post-translational protein modification that regulates many biological conditions [1, 2, 3, 4] . Trip12 is a HECT-type E3 ubiquitin ligase that ubiquitinates ARF and APP-BP1 [5, 6] . However, the significance of Trip12 in vivo is largely unknown. Here we show that the ubiquitin ligase activity of Trip12 is indispensable for mouse embryogenesis. A homozygous mutation in Trip12 (Trip12 mt/mt ) that disrupts the ubiquitin ligase activity resulted in embryonic lethality in the middle stage of development. Trip12 mt/mt embryos exhibited growth arrest and increased expression of the negative cell cycle regulator p16 [7, 8, 9, 10] . In contrast, Trip12 mt/mt ES cells were viable. They had decreased proliferation, but maintained both the undifferentiated state and the ability to differentiate. Trip12 mt/mt ES cells had increased levels of the BAF57 protein (a component of the SWI/SNF chromatin remodeling complex) and altered gene expression patterns. These data suggest that Trip12 is involved in global gene expression and plays an important role in mouse development.
Introduction
Protein ubiquitination plays an important role in various cellular events [1, 2, 3, 4] . Ubiquitination occurs through sequential steps that are catalyzed by activating (E1), conjugating (E2), and ligase (E3) enzymes. In this reaction, the specificity for distinct substrates is determined by the ubiquitin ligase enzymes. From a mechanistic standpoint, ubiquitin ligases fall into two groups: HECT domain E3s and RING domain E3s [11, 12, 13] . The HECT family contains a diverse N-terminal region and a conserved C-terminal HECT domain, which has a reactive Cys residue. HECT-type ubiquitin ligases form a thioester intermediate with ubiquitin at the conserved Cys residue before transferring ubiquitin to the target proteins [12, 13] .
Trip12 encodes a HECT domain containing an E3 ubiquitin ligase, which was originally identified as a thyroid hormone receptorinteracting protein in a yeast two-hybrid screen [14] . Recent reports indicate that Trip12 ubiquitinates ARF and APP-BP1 and regulates BAF57 turnover [5, 6, 15] . In this study, we showed that the ubiquitin ligase activity of Trip12 is essential for mouse development. We generated mice in which the coding region of the HECT domain within Trip12 was mutated (Trip12 mt/mt mice). Targeted inactivation of Trip12 resulted in abnormal p16 induction and embryonic lethality in mice. We also found that Trip12 mt/mt ES cells were viable but had decreased cell cycle progression. Trip12 mt/mt ES cells had accumulated levels of the BAF57 protein and different gene expression patterns. Our data suggest that Trip12 is involved in global gene expression and is essential for mouse development.
Results

Generation of Trip12 mutant mice
To study the function of Trip12 in vivo, we generated Trip12 mutant mice by replacing exon 33 with FLAG and HA epitope tag sequences in frame and a neomycin resistant gene. This mutant Trip12 lacks the catalytic core for the ubiquitin ligase activity and has FLAG and HA epitope sequences at the C-terminus (Fig. 1A) . The targeting vector was linearized, electroporated into ES cells and ES cells were grown under G418 selection. Selected ES cell clones were verified by Southern blot analysis and several clones were correctly targeted (Fig. 1B) . We also detected the mutant Trip12 proteins in the targeted clones by Western blotting using an anti-HA antibody (Fig. 1C) . Heterozygous Trip12 +/mt mice were viable and fertile and did not exhibit any overt phenotype. To elucidate the Trip12 expression pattern in mouse embryos, anti-HA staining was performed. As shown in Fig. 1D , Trip12 is ubiquitously expressed in the embryo at E9.5 (Fig. 1D ).
TRIP12 ubiquitin ligase activity is essential for mouse embryogenesis
Trip12
+/mt mice were intercrossed in order to produce Trip12 mt/mt mice. However, no Trip12 mt/mt mice were generated, suggesting that the ubiquitin ligase activity of Trip12 is essential for mouse development. To characterize the timing of this embryonic lethality, embryos derived from the Trip12 +/mt intercross were genotyped at different stages of gestation. Trip12
, and Trip12 mt/mt embryos were born at the expected Mendelian ratio and were viable up to E8.5, while no Trip12 mt/mt embryos were observed between E11.5 and E13.5 (Table 1) . From these results, we concluded that Trip12 plays an important role in mouse embryogenesis.
Phenotypes of Trip12 mt/mt embryos
To characterize the nature of this embryonic lethality, we studied the morphology of embryos from timed Trip12 +/mt intercrosses at different stages of gestation. An examination of these embryos at various developmental stages revealed that the development of Trip12 mt/mt embryos appeared to be delayed at E8.5 ( Fig. 2A) . Despite this developmental delay, there were no gross morphological abnormalities in Trip12 mt/mt embryos. We also confirmed that the number of somites was decreased in Trip12 mt/mt embryos compared to wild-type embryos at E9.5 (Fig. 2B) .
The Trip12 mt/mt embryos were further characterized histologically at different developmental stages. In addition to a developmental delay, Trip12 mt/mt embryos had abnormal placenta formation (Fig. 2C) . Normal labyrinth formation was not observed and a number of erythrocytes accumulated in the placenta of Trip12 mt/mt embryos ( Fig. 2C right panel) . This phenotype might be caused by impaired development of the allantois [16] .
Given Trip12 enzymatic activity which is involved in ARF regulation (4), we examined whether mutant show altered expression of ARF and related proteins which could explain the developmental arrest of Trip12 mt/mt embryos. Therefore, we examined the expression levels of several cell cycle-related genes and found that p16 and ARF expression levels were increased in Trip12 mt/mt embryos (Fig. 2D ). p16 is a cyclin-dependent kinase inhibitor and ARF increases p53 protein stability and promotes p53-dependent cell cycle arrest [7, 8, 9, 10] . However, the expression level of p21, a p53 target gene, was virtually unchanged. In addition, mutant embryo didn't show increased apoptosis compared to wild type embryo at corresponding developmental stage (Fig. S1 ). These data indicate that the embryonic lethality of Trip12 mt/mt mice may be caused by abnormal p16 induction rather than p53 activation.
Generation and characterization of Trip12 mt/mt ES cells
To further investigate the function of Trip12, we generated two Trip12 mt/mt ES cell clones [17 and #2] (Fig. 3A, 3B , and 3C). We examined the ability of Trip12 mt/mt ES cells to self-renew and differentiate. The expression levels of Nanog and Oct-4 were comparable in the two Trip12 mt/mt ES cell clones and wild-type cell cultures with or without LIF (Fig. 3D ). To assess whether ES cell differentiation was affected, we compared embryoid body (EB) formation on days 0 and 10. Trip12 mt/mt ES cells displayed the same EB morphology (data not shown), and the expression patterns of endodermal (AFP)-, mesodermal (Flk-1)-, and ectodermal (NCAM)-specific genes were also similar between wild-type and Trip12 mt/mt ES cells (Fig. 3E) . These results suggest that Trip12 has a minor role in ES cell differentiation.
Trip12
mt/mt ES cells exhibit cell cycle defects Next, we tested whether the Trip12 mutation leads to a defect in cell proliferation. The MTT assay showed that Trip12 mt/mt ES cells had decreased cell growth (Fig. 4A) . Therefore, we analyzed cell cycle progression by flow cytometry, and found that the G2-M and SubG1 populations were increased in Trip12 mt/mt ES cells (Fig. 4B) . We further examined the expression levels of p16, ARF, and p21. Unexpectedly, the expression levels of these genes were virtually unchanged in the cells (Fig. 4C) . It was previously reported that Trip12 ubiquitinates ARF and inhibits p53-dependent transcription [6] . However, there were no detectable alterations in p53-related protein levels in Trip12 mt/mt ES cells (Fig. 4D ).
Trip12 negatively regulates BAF57 protein stability and is involved in global gene expression in ES cells
Recent reports also suggest that Trip12 regulates BAF57 protein turnover [15] . Therefore, we examined whether inactivation of the Trip12 ubiquitin ligase activity affects the stability of BAF57. As shown in Fig. 5A , the endogenous BAF57 protein levels were increased in Trip12 mt/mt ES cells (Fig. 5A ). We also confirmed that endogenous BAF57 interacts with Trip12mt from targeted allele in ES cells (Fig. 5B) . In addition, cycloheximide experiments showed that the turnover rate of endogenous BAF57 was decreased in Trip12 mt/mt ES cells (t 1/2 &6 h) compared to that in wild-type cells (t 1/2 <4 h) (Fig. 5C ). As shown in Fig. 5D , ectopically expressed wild type and mutant Trip12 were interacting with GST-BAF57 and mutant Trip12 showed stronger interaction than wild type suggesting that loss of catalytic activity of Trip12 resulted in decreased dissociation of BAF57 from Trip12. These data demonstrate that the ubiquitin ligase activity of Trip12 is required for BAF57 turnover in ES cells. BAF57 is a component of the SWI/SNF chromatin remodeling complex and involved in a variety of cellular processes [18, 19, 20, 21, 22, 23, 24, 25, 26] . Therefore, a gene expression study using microarray analysis was performed to elucidate the underlying mechanism that leads to cell proliferation defects in Trip12 mt/mt ES cells. Microarray analysis of variance identified a total of 7635 genes that were significantly expressed in wild-type and Trip12 mt/mt ES cells (p-values,0.05). To identify statistically significant functional categories by gene ontology, we selected genes that had greater than 2-fold changes in expression and placed these genes into DAVID [27] . As shown in Fig. 5D , both up-and down-regulated genes were enriched in the developmental process (Fig. 5D ). These data suggest that Trip12 regulates gene expression by destabilizing BAF57 during mouse development.
Discussion
In this report, we have determined that the E3 ubiquitin ligase activity of Trip12 is indispensable for mouse development. Previous reports indicated that Trip12 promotes the ubiquitination and degradation of ARF [6] . The down-regulation of Trip12 expression stabilizes ARF and enhances ARF-dependent, p53-mediated cell cycle arrest in normal human fibroblasts [6] . However, in our experiments, the p53 pathway was not activated in either Trip12 mt/mt mice or Trip12 mt/mt ES cells. Although Trip12 mt/mt mice had increased ARF expression levels, the p21 (which is a well known p53 target gene) expression levels were unchanged in these mice. These findings suggest that the growth arrest phenotype of Trip12 mt/mt mice was caused by p16 expression rather than ARF induction. Previous reports also showed that Trip12-mediated ARF ubiquitination is inhibited by c-Myc [6] . It is known that c-Myc expression levels are higher in mouse embryos and ES cells compared to differentiated cells [17, 28, 29, 30] . Considering these results, we speculate that Trip12 minimally contributes to ARF ubiquitination during mice embryogenesis because of elevated c-Myc expression. On one hand, our experiments showed that BAF57 protein stability was regulated by Trip12-mediated ubiquitination and that the expression profiles of several genes were changed between wild-type and Trip12 mt/mt ES cells. This finding suggests that the ubiquitination activity of Trip12 is tightly regulated by individual target proteins. Further experiments using conditional knockout approaches and the Trip12 protein complex that is purified from different cell types may help elucidate the exact in vivo functions of the Trip12 protein.
Materials and Methods
Cell culture and embryoid body (EB) formation
E14 ES cells (ATCC) were maintained on mouse embryo fibroblast (MEF) feeder cell layers in Dulbecco-modified Eagle medium containing 14% KnockOut Serum Replacement (Invirtogen), 1% fetal bovine serum, 100 units/ml LIF, 0.1 mM nonessential amino acids, 1 mM sodium pyruvate, 2 mM Lglutamine, and 100 mM 2-mercaptoethanol. For EB formation assays, 2610 5 cells were seeded into 35 mm low attachment sterile cell plate in 2 ml ES cell medium without LIF. Fresh medium was provided every two days.
Targeting vectors and generation of Trip12 mutant mice
The targeting vectors for Trip12 were constructed by inserting FLAG and HA epitope tag sequences in frame and Neo or IREShyg cassette into the exon 33 of the mouse Trip12 genome.
Correctly targeted ES cell clone were injected into C57BL/6 blastocysts, producing chimeric mice. Highly chimeric males were mated to females, and then the progeny were intercrossed. All experiments were performed in accordance with the Declaration of Helsinki and were approved by University of Tsukuba Ethics Committee for Animal Experiments (approval ID:040042). 
Western Blot
Cells were lysed in TNE buffer [10 mM Tris-HCl (pH 7.8), 1% NP-40, 150 mM NaCl, 1 mM EDTA, 1 mM phenylmethylsulfonyl fluoride, and 1 mg/ml aprotinin]. The proteins were separated by SDS-PAGE, transferred onto PVDF membranes (Millipore), immunoblotted with indicated antibodies. The antibodies employed in this study included mouse monoclonal antibodies specific for b-Actin (Sigma); rat monoclonal antibody for HA (Roche) and ARF (Calbiochem). Rabbit polyclonal antibody for BAF57 (GeneTex) and Trip12 (Bethyl Laboratories).
Real-time RT-PCR
Embryos and cells were homogenized in 1 ml of sepasol (nacalai tesque) and total RNA was extracted according to the instruction manual. cDNA was synthesized from total RNA using RevatraAce reverse transcriptase (Toyobo) and random primers. Real-time PCRs were performed to amplify fragments representing for the indicated mRNA expression. We used primers 59-CATCTGGAG-CAGCATGGAGTC-39 and 59-GGGTACGACCGAAAGAGT-TCG-39 for p16, 59-GTTCTTGGTCACTGTGAGGATTCAG-39 and 59-CCATCATCATCACCTGGTCCAG-39 for ARF, 59-TTGCACTCTGGTGTCTGAGC-39 and 59-TGCGCTTGGA-GTGATAGAAA-39 for p21, 59-TTGGGTCTCAGGCAAACT-CT-39 and 59-CTGTTGGCCCTTTTGTTTTG-39 for p27, 59-AGTACCTCAGCCTCCAGCAGAT-39 and 59-GCTTGCACT-TCATCCTTTGGTT-39 for Nanog, 59-CACGAGTGGAAAG-CAACTCA-39 and 59-TTCATGTCCTGGGACTCCTC-39 for Oct-4, 59-CATGAACAGGTTCATCTATG-39 and 59-GTTGT-CAGCTTTGCAGCATG-39 for AFP, 59-TGTCTATGTTCGA-GATTACAG-39 and 59-CATTGAGGTTTGAAATCGAC-39 for Flk-1, 59-GGTCATTGTGAATGTACCAC-39 and 59-CCTTTG-TCCAGCTCATGGTG-39 for NCAM,
Cycloheximide treatment
Cells were treated with 100 mg/ml cycloheximide to prevent de novo protein synthesis, and lysed at various time points following cycloheximide treatment. The proteins were then separated by SDS-PAGE and detected by immunoblotting.
Whole mount immunostaining
Whole mount immunostaining of embryos were performed as described previously [31] . Microarray procedure and data analysis
The microarray procedure was performed as described in the Affymetrix GeneChip Expression Analysis manual (Affimetrix). Each array was analysed using GeneSpring (Agilent) program. Patterns were analysed to identify functional categories using Database for Annotation, Visualization and Integrated Discovery (DAVID) (http:// david.abcc.ncifcrf.gov) [27] . We used the functional annotation tool program and reported only GO-TERM_BP (Biological process) that had p-values of ,0.05.
Statistical analysis
All the data are representative of at least three different experiments. Statistical analysis was performed using t-test. 
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